ABRA anticorps (Middle Region)
-
- Antigène Voir toutes ABRA Anticorps
- ABRA (Actin-Binding rho Activating Protein (ABRA))
-
Épitope
- Middle Region
-
Reactivité
- Humain
-
Hôte
- Lapin
-
Clonalité
- Polyclonal
-
Conjugué
- Cet anticorp ABRA est non-conjugé
-
Application
- Western Blotting (WB)
- Purification
- Purified
- Immunogène
- ABRA antibody was raised in rabbit using the middle region of ABRA as the immunogen
- Top Product
- Discover our top product ABRA Anticorps primaire
-
-
- Indications d'application
-
WB: 0.2-1 µg/mL
Optimal conditions should be determined by the investigator. - Commentaires
-
ABRA Blocking Peptide, catalog no. 33R-7785, is also available for use as a blocking control in assays to test for specificity of this ABRA antibody
- Restrictions
- For Research Use only
-
- Format
- Lyophilized
- Concentration
- Lot specific
- Buffer
- Lyophilized powder. Add 50 µL of distilled water. Final antibody concentration is 1 mg/mL in PBS buffer.
- Conseil sur la manipulation
- Avoid repeated freeze/thaw cycles.
- Stock
- 4 °C/-20 °C
- Stockage commentaire
- Store at 4 °C, following reconstitution, aliquot and store at -20 °C.
-
- Antigène
- ABRA (Actin-Binding rho Activating Protein (ABRA))
- Autre désignation
- ABRA (ABRA Produits)
- Synonymes
- anticorps STARS, anticorps C130068O12Rik, anticorps Ms1, anticorps Stars, anticorps actin binding Rho activating protein, anticorps actin-binding Rho activating protein, anticorps ABRA, anticorps Abra
- Sujet
- ABRA acts as an activator of serum response factor (SRF)-dependent transcription possibly by inducing nuclear translocation of MKL1 or MKL2 and through a mechanism requiring Rho-actin signaling. Synonyms: Polyclonal ABRA antibody, Anti-ABRA antibody, actin-binding Rho activating protein antibody, STARS antibody.
- Pathways
- Protein targeting to Nucleus
-